Polarityte, Inc.
PTEDelisted- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001076682
Polarityte, Inc. was delisted in 2022; its insiders filed their last Form 4 on Jan 30, 2023; 46 institutions reported holding it in 13F filings for Q1 2022, worth $4.07M in total; no superinvestor held it.
Open-market trades, last 90 days
Open-market purchases (P) and sales (S) by Polarityte, Inc. insiders, counted by Form 4 filing. Trades with a flagged price and duplicate filings are left out.
- Open-market buys
- 0 filings
- Open-market sells
- 0 filings
- Insiders trading
- 0
- Net value
- $0
- Purchases minus sales
Insider roster
Directors, officers and 10% owners who have filed a Form 4 for Polarityte, Inc., current and former, most recent filer first. Last reported holding is the position after the last non-derivative trade in their latest filing.
| Name | Title | Last reported holding | Last filing | Filings, past year |
|---|---|---|---|---|
| Dyer Jeffrey Hansen | Director | 44,339 | Jan 30, 2023 | 0 |
| Nolet Chris | Director | 14,403 | Jan 17, 2023 | 0 |
| Cohen Peter A | Director | 58,143 | Oct 4, 2022 | 0 |
| Bogan Willie C. | Director | 53,792 | Oct 4, 2022 | 0 |
| Seaburg David B | Director | 112,702 | Oct 4, 2022 | 0 |
| Hague Richard | Chf. Exec. Off. & Pres. | 45,794 | Jul 19, 2022 | 0 |
| Hoyler Cameron J. | Gen. Counsel & Exec. VP | 36,423 | Jul 19, 2022 | 0 |
| Patterson Jacob Alexander | Chief Financial Officer | 15,480 | Jul 19, 2022 | 0 |
Insider trades
Each row adds up one type of transaction in one Form 4 filing. Only open-market purchases (P) and sales (S) are shown by default; use the filters to see grants, option exercises and other codes.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Aug 17, 2022 (view filing) | Aug 17 | Same day | Cohen Peter ADirector | SSale | −8.55K | $1.28 | −$11.0K | −54.2%7.24K after | |
| Aug 16, 2022 (view filing) | Aug 16 | Same day | Cohen Peter ADirector | SSale | −15.1K | $1.33 | −$20.1K | −2.0%757.5K after | Amended |
| Oct 21, 2021 (view filing) | Oct 19 | 2 days | Seaburg David BDirector | SSale | −31.0K | $0.55 | −$17.1K | −2.3%1.34M after | |
| Aug 10, 2021 (view filing) | Aug 9 | 1 day | Hague RichardChf. Oper. Off. & Pres. | SSale | −10.2K | $0.83 | −$8.47K | −1.2%814.1K after | 2 lots |
| Jul 20, 2021 (view filing) | Jul 19 | 1 day | Seaburg David BChief Executive Officer | SSale | −31.0K | $0.71 | −$22.0K | −2.8%1.09M after | 2 lots |
| Jul 20, 2021 (view filing) | Jul 19 | 1 day | Hague RichardChf. Oper. Off. & Pres. | SSale | −12.6K | $0.71 | −$8.95K | −1.6%789.0K after | 2 lots |
| Jul 1, 2021 (view filing) | Jun 29 | 2 days | Hague RichardChf. Oper. Off. & Pres. | SSale | −6.31K | $1.02 | −$6.44K | −0.8%805.2K after |